Aims. The aim of this Service is to minimise the possible harmful effects of supply of substances liable to misuse by both increasing adherence and reducing supplies leaking into the illicit market. This Service supports adherence with Drug Misuse and Dependence UK Guidelines on Clinical Management, published by the Department of Health and Methadone and Buprenorphine for the Management of Opioid Dependence (TA114) published by National Institute for Health and Clinical Excellence (NICE).
Appears in 7 contracts
Samples: Prescribed Treatment Agreement, Prescribed Treatment Agreement, psnc.org.uk
Aims. The aim of this Service scheme is to minimise the possible harmful effects of supply of substances liable to misuse by both increasing adherence compliance and reducing supplies leaking into the illicit market. This Service service supports adherence compliance with Drug Misuse and Dependence UK Guidelines on Clinical Management, published by the Department of Health and Methadone and Buprenorphine for the Management of Opioid Dependence (TA114) published by National Institute for Health and Clinical Excellence (NICE).
Appears in 1 contract
Samples: psnc.org.uk
